Use of Transcutaneous and Percutaneous Ablation for the Treatment of Benign and Malignant Tumors of the Breast

a. The lesion must be easily visualized on ultrasound.
b. The diagnosis of fibroadenoma must be confirmed histologically on core biopsy prior to treatment.
c. The diagnosis of fibroadenoma must be concordant with the imaging findings, patient history, and physical exam.
d. Lesions should be less than 4 cm in largest diameter.